STOCKHOLM--(BUSINESS WIRE)--Regulatory News: At Diamyd Medical’s (Pink Sheets:DMYDY) (STO:DIAM.B) Annual General Meeting on December 9, Elisabeth Lindner, President and CEO of Diamyd, said that the past year was one of the most significant years in the history of the company and that the foundation has been laid upon which a new Swedish pharmaceutical company can be built.
